Natural remedies for Herpes simplex

Alternative Medicine Review

Volumn 11, Issue 2, 2006, Pages 93-101

  Gaby, Alan R ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ALPHA TOCOPHEROL; ARGININE; ASCORBIC ACID; COPPER; LYSINE; LYSINE DERIVATIVE; MAGNESIUM; MELISSA OFFICINALIS EXTRACT; RIBOFLAVIN; SUCCINATE LITHIUM; THIAMINE; UNCLASSIFIED DRUG; ZINC DERIVATIVE; ZINC MONOGLYCEROLATE; ZINC OXIDE; ZINC OXIDE GLYCINE; ZINC SULFATE;

ANAPHYLAXIS; CLINICAL FEATURE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG SAFETY; DRY SKIN; HEALING; HEPATITIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; KIDNEY FAILURE; LEMON; MELISSA OFFICINALIS; NAUSEA; NONHUMAN; PAIN; PRESCRIPTION; PRURITUS; RECURRENT DISEASE; REVIEW; SKIN BURNING SENSATION; SKIN IRRITATION; SKIN STINGING SENSATION; SKIN TINGLING; SYMPTOM; THORAX PAIN; VITAMIN SUPPLEMENTATION; VOMITING;

ADENOSINE MONOPHOSPHATE; ANIMALS; ASCORBIC ACID; CITRUS; COMPLEMENTARY THERAPIES; HERPES SIMPLEX; HUMANS; LYSINE; ORGANOMETALLIC COMPOUNDS; PHYTOTHERAPY; RATS; SUCCINATES; VITAMIN E; ZINC;

EID: 33745892897     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Nalder BN, Mahoney AW, Ramakrishnan R, Hendricks DG. Sensitivity of the immunological response to the nutritional status of rats. J Nutr 1972;102:535-541.
2. Bernstein J, Alpert S, Nauss KM, Suskind R. Depression of lymphocyte transformation following oral glucose ingestion. Am J Clin Nutr 1977;30:613.
3. Iwata K. Toxins produced by Candida albicans. Contrib Microbiol Immunol 1977;4:77-85.
4. Truss CO. Tissue injury induced by Candida albicans. Mental and neurologic manifestations. J Orthomolec Psychiatry 1978;7:17-37.
5. Kagan C. Lysine therapy for Herpes simplex. Lancet 1974;1:137.
6. Griffith RS, DeLong DC, Nelson JD. Relation of arginine-lysine antagonism to Herpes simplex growth in tissue culture. Chemotherapy 1981;27:209-213.
7. Miller CS, Foulke CN. Use of lysine in treating recurrent oral Herpes simplex infections. Gen Dent 1984;32:490-493.
8. Griffith RS, Norins AL, Kagan C. A multicentered study of lysine therapy in Herpes simplex infection. Dermatologica 1978;156:257-267.
9. McCune MA, Perry HO, Muller SA, O'Fallon WM. Treatment of recurrent Herpes simplex infections with L-lysine monohydrochloride. Cutis 1984;34:366-373.
10. Griffith RS, Walsh DE, Myrmel KH, et al. Success of L-lysine therapy in frequently recurrent Herpes simplex infection. Treatment and prophylaxis. Dermatologica 1987;175:183-190.
11. Milman N, Scheibel J, Jessen O. Lysine prophylaxis in recurrent Herpes simplex labialis: a double-blind, controlled crossover study. Acta Derm Venereol 1980;60:85-87.
12. DiGiovanna JJ, Blank H. Failure of lysine in frequently recurrent Herpes simplex infection. Treatment and prophylaxis. Arch Dermatol 1984;120:48-51.
13. Thein DJ, Hurt WC. Lysine as a prophylactic agent in the treatment of recurrent Herpes simplex labialis. Oral Surg Oral Med Oral Pathol 1984;58:659-666.
14. Flodin NW. The metabolic roles, pharmacology, and toxicology of lysine. J Am Coll Nutr 1997;16:7-21.
15. Meredith CN, Wen ZM, Bier DM, et al. Lysine kinetics at graded lysine intakes in young men. Am J Clin Nutr 1986;43:787-794.
16. Duncan AM, Ball RO, Pencharz PB. Lysine requirement of adult males is not affected by decreasing dietary protein. Am J Clin Nutr 1996;64:718-725.
17. Hurrell RF, Carpenter KJ. Mechanisms of heat damage in proteins. 8. The role of sucrose in the susceptibility of protein foods to heat damage. Br J Nutr 1977;38:285-297.
18. Goldberg T, Cai W, Peppa M, et al. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 2004;104:1287-1291.
19. No author listed. Herpes disappear with lysine therapy. Modern Med 1980;April:17.
20. Milman N, Scheibel J, Jessen O. Failure of lysine treatment in recurrent Herpes simplex labialis. Lancet 1978;2:942.
21. Murata A. Virucidal activity of vitamin C for prevention and treatment of viral diseases. In: Hasegawa T, ed. Proceedings of the First International Congress IAMS, Science Council of Japan. 1975.
22. Holden M, Molloy E. Further experiments on the inactivation of herpes virus by vitamin C (L-ascorbic acid). J Immunol 1937;33:251-257.
23. Dainow I. Treatment of herpes with ascorbic acid. Ann Dermatol Syph 1936;7:817-827.
24. Klenner F. The treatment of poliomyelitis and other virus diseases with vitamin C. South Med Surg 1949;July:209-214.
25. Cathcart RF 3rd. Vitamin C in the treatment of acquired immune deficiency syndrome (AIDS). Med Hypotheses 1984;14:423-433.
26. Terezhalmy GT, Bottomley WK, Pelleu GB. The use of water-soluble bioflavonoid-ascorbic acid complex in the treatment of recurrent herpes labialis. Oral Surg Oral Med Oral Pathol 1978;45:56-62.
27. Middleton E Jr. The flavonoids. TIPS 1984;5:335-338.
28. Shlomai J, Asher Y, Gordon YJ, et al. Effect of zinc ions on the synthesis of Herpes simplex virus DNA in infected BSC-1 cells. Virology 1975;66:330-335.
29. Fridlender B, Chejanovsky N, Becker Y. Selective inhibition of Herpes simplex virus type I DNA polymerase by zinc ions. Virology 1978;84:551-554.
30. Gupta P, Rapp F. Effect of zinc ions on synthesis of Herpes simplex vims type 2-induced polypeptides. Proc Soc Exp Biol Med 1976;152:455-458.
31. Gordon YJ, Asher Y, Becker Y. Irreversible inhibition of Herpes simplex virus replication in BSC-1 cells by zinc ions. Antimicrob Agents Chemother 1975;8:377-380.
32. Tennican P, Carl G, Frey J, et al. Topical zinc in the treatment of mice infected intravaginally with herpes genitalis virus. Proc Soc Exp Biol Med 1980;164:593-597.
33. Tennican PO, Carl GZ, Chvapil M. The diverse effects of topical and systemic administration of zinc on the virulence of Herpes simplex genitalis. Life Sci 1979;24:1877-1883.
34. Wahba A. Topical application of zinc-solutions: a new treatment for Herpes simplex infections of the skin? Acta Derm Venereol 1980;60:175-177.
35. Brody I. Topical treatment of recurrent Herpes simplex and post-herpetic erythema multiforme with low concentrations of zinc sulphate solution. Br J Dermatol 1981;104:191-194.
36. Finnerty EF. Topical zinc in the treatment of Herpes simplex. Cutis 1986;37:130-131.
37. Apisariyakulm A, Buddhasukh D, Apisariyakul S, Ternai B. Zinc monoglycerolate is effective against oral herpetic sores. Med J Aust 1990;152:54.
38. Godfrey HR, Godfrey NJ, Godfrey JC, Riley D. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine. Altern Ther Health Med 2001;7:49-56.
39. Eby GA, Halcomb WW. Use of topical zinc to prevent recurrent Herpes simplex infection: review of literature and suggested protocols. Med Hypotheses 1985;17:157-165.
40. Jones R. Genital herpes and zinc. Med J Aust 1979;1:286.
41. Fitzherbert JC. Genital herpes and zinc. Med J Aust 1979;1:399.
42. Gordon AM. Effects of adjuvant therapy with zinc in human immunodeficiency infection. J Am Coll Nutr 1992;11:601.
43. Fosmire GJ. Zinc toxicity. Am J Clin Nutr 1990;51:225-227.
44. Starasoler S, Haber GS. Use of vitamin E oil in primary herpes gingivostomatitis in an adult. N Y State Dent J 1978;44:382-383.
45. Nead DE. Effective vitamin E treatment for ulcerative herpetic lesions. Dent Surv 1976;52:50-51.
46. Fink M, Fink J. Treatment of Herpes simplex by alpha-tocopherol (vitamin E). Br Dent J 1980;148:246.
47. Blue WT, Macias EA, Sklar SH. Activity of AMP against experimental Herpes simplex virus type 1 infections in mice. Antimicrob Agents Chemother 1983;24:807-809.
48. Blue WT, Winland RD, Stobbs DG, et al. Effects of adenosine monophosphate on the reactivation of latent Herpes simplex virus type 1 infections of mice. Antimicrob Agents Chemother 1981;20:547-548.
49. Fraser-Smith EB, Smee DF, Matthews TR. Lack of efficacy of AMP against recrudescent genital herpes infections in guinea pigs. Antimicrob Agents Chemother 1983;24:611-612.
50. Sklar SH, Wigand JS. Herpes zoster. Br J Dermatol 1981;104:351-352.
51. Sklar SH, Buimovici-Klein E. Adenosine in the treatment of recurrent herpes labialis. Oral Surg Oral Med Oral Pathol 1979;48:416-417.
52. Koytchev R, Alken RG, Dundarov S. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis. Phytomedicine 1999;6:225-230.
53. Wolbung RH, Leonhardt K. Local therapy of Herpes simplex with dried extract from Melissa officinalis. Phytomedicine 1994;1:25-31.
54. Skinner GR, Hartley C, Buchan A, et al. The effect of lithium chloride on the replication of Herpes simplex virus. Med Microbiol Immunol (Berl) 1980;168:139-148.
55. Bschor T. Complete suppression of recurrent herpes labialis with lithium carbonate. Pharmacopsychiatry 1999;32:158.
56. Amsterdam JD, Maislin G, Rybakowski J. A possible antiviral action of lithium carbonate in Herpes simplex virus infections. Biol Psychiatry 1990;27:447-453.
57. Lieb J. Immunopotentiation and inhibition of herpes virus activation during therapy with lithium carbonate. Med Hypotheses 1981;7:885-890.
58. Skinner GR. Lithium ointment for genital herpes. Lancet 1983;2:288.